CASE REPORT. Membranoproliferative associated with type II in a renal transplant patient with hepatitis C. Glomerulonefrite membranoproliferativa em. Disease definition. Dense deposit disease, a histological subtype of MPGN (see this term) is an idiopathic chronic progressive kidney disorder distinguished by. Glomerulonefrite membranoproliferativa. Classificação Até achados estruturais e histopatológico fisiopatologia e.
|Published (Last):||20 October 2006|
|PDF File Size:||13.38 Mb|
|ePub File Size:||19.58 Mb|
|Price:||Free* [*Free Regsitration Required]|
There were no other organ manifestations of. N Engl J Med ; Patients with systemic lupus erythematosus or any kind of autoimmune disease were not included in the present analysis. This diagnostic was surprising since the patient presented with sustained negative viral load, but there are other reported cases in the literature of HCV-related glomerulonephritis in patients with undetectable HCV-RNA Post-transplantation morbidity in renal transplant patients with hepatitis C virus HCV infection may be partially explained by the risk of de novo or recurrent HCV associated glomerulopathieswhich can lead to allograft dysfunction.
In our case, the treatment with rituximab resulted in a favourable outcome, although a longer follow-up period may be needed to evaluate the clinical response, since other studies reported high relapse rates.
Orphanet: Glomerulonefrite membranoproliferativa tipo 2
J Am Soc Nephrol ;7 For these reasons we decided to treat the patient with this drug. Crioglobulinemia; glomerulonefrite membranoproliferativa; hepatite C; membranoprolifreativa transplante renal. For all other comments, please send your remarks via contact us.
Hepatitis C virus antibody status and survival after renal transplantation: The main goal of antiretroviral therapy before transplantation is to achieve sustained viral response, because the risk of hepatic and extra hepatic complications is reduced. Detailed information Professionals Clinical genetics review English Two months after the last dose of rituximab, the SCr improved to 1. Kidney Int ;77 8: Clin J Am Soc Nephrol ;4 1: Hepatitis C virus-associated glomerulonephritis without hepatitis Membranopfoliferativa virus in the blood.
The schedule and dosage recommended for this drug in renal transplant is not yet defined. Hepatitis C and kidney transplantation. To date, there are no studies of this therapy in renal transplant and randomized controlled trials are needed There were no infectious complications during the treatment with rituximab.
Other glomerular diseases have also been reported, such as membranous nephropathy, minimal change disease, thrombotic microangiopathy, acute transplant glomerulopathy and chronic transplant glomerulopathies 1,4,5. Int J Nephrol ; doi: Rituximab, a human mouse chimeric monoclonal antibody directed against CD20 antigen on B lymphocytes, has recently proved to be effective on the treatment of this entity, however, the ideal dosage of this drug membranoproluferativa not yet been defined.
There have been several case reports and studies showing the effectiveness of Rituximab in the treatment of glomerular diseases, membranoprolifetativa, more randomized studies are needed 7,8,12,21, His baseline serum creatinine SCr was 1.
An allograft biopsy was performed and showed lesions compatible with MPGN.
Fabrizi F, Martin P, V. The most common HCV-related nephropathy is membranoproliferative glomerulonephritis MPGNusually in the context of cryoglobulinaemia 6,7.
Os anticorpos antinuclear e anti-double stranded DNA foram negativos. All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License. The glomerulonefriye of this entity is a complex, nonconsensual issue and represents a challenge to clinicians. Two months after the last dose of rituximab, hypertension resolved, serum creatinine improved 1.
Other search option s Alphabetical list. His baseline serum creatinine after transplantation was 1.
Glomerulonefrite membranoproliferativa by Isabela Alcântara on Prezi
The patient did not receive any previous antiviral therapy. In Septemberhis SCr raised to 1. The patient was lost for follow-up. Autoimmun Rev ;10 C4d staining was negative.